312 related articles for article (PubMed ID: 33253987)
1. Ultra-Early Venous Thromboembolism (VTE) Prophylaxis in Spontaneous Intracerebral Hemorrhage (sICH).
Kananeh MF; Fonseca-Paricio MJ; Liang JW; Sullivan LT; Sharma K; Shah SO; Vibbert MD
J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105476. PubMed ID: 33253987
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological deep vein thrombosis prophylaxis does not lead to hematoma expansion in intracerebral hemorrhage with intraventricular extension.
Wu TC; Kasam M; Harun N; Hallevi H; Bektas H; Acosta I; Misra V; Barreto AD; Gonzales NR; Lopez GA; Grotta JC; Savitz SI
Stroke; 2011 Mar; 42(3):705-9. PubMed ID: 21257826
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose versus Therapeutic Range Intravenous Unfractionated Heparin Prophylaxis in the Treatment of Patients with Severe Aneurysmal Subarachnoid Hemorrhage After Aneurysm Occlusion.
Kunz M; Siller S; Nell C; Schniepp R; Dorn F; Huge V; Tonn JC; Pfister HW; Schichor C
World Neurosurg; 2018 Sep; 117():e705-e711. PubMed ID: 29959066
[TBL] [Abstract][Full Text] [Related]
4. Early vs. late enoxaparin for the prevention of venous thromboembolism in patients with ICH: A double blind placebo controlled multicenter study.
Qian C; Huhtakangas J; Juvela S; Bode MK; Tatlisumak T; Savolainen M; Numminen H; Ollikainen J; Luostarinen L; Kupila L; Tetri S
Clin Neurol Neurosurg; 2021 Mar; 202():106534. PubMed ID: 33578226
[TBL] [Abstract][Full Text] [Related]
5. Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage.
Sprügel MI; Sembill JA; Kuramatsu JB; Gerner ST; Hagen M; Roeder SS; Endres M; Haeusler KG; Sobesky J; Schurig J; Zweynert S; Bauer M; Vajkoczy P; Ringleb PA; Purrucker JC; Rizos T; Volkmann J; Muellges W; Kraft P; Schubert AL; Erbguth F; Nueckel M; Schellinger PD; Glahn J; Knappe UJ; Fink GR; Dohmen C; Stetefeld H; Fisse AL; Minnerup J; Hagemann G; Rakers F; Reichmann H; Schneider H; Wöpking S; Ludolph AC; Stösser S; Neugebauer H; Röther J; Michels P; Schwarz M; Reimann G; Bäzner H; Schwert H; Classen J; Michalski D; Grau A; Palm F; Urbanek C; Wöhrle JC; Alshammari F; Horn M; Bahner D; Witte OW; Guenther A; Hamann GF; Lücking H; Dörfler A; Schwab S; Huttner HB
J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):783-791. PubMed ID: 30992334
[TBL] [Abstract][Full Text] [Related]
6. Safety of Prophylactic Heparin in the Prevention of Venous Thromboembolism After Spontaneous Intracerebral Hemorrhage: A Meta-analysis.
Pan X; Li J; Xu L; Deng S; Wang Z
J Neurol Surg A Cent Eur Neurosurg; 2020 May; 81(3):253-260. PubMed ID: 31962358
[TBL] [Abstract][Full Text] [Related]
7. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis.
Kiphuth IC; Staykov D; Köhrmann M; Struffert T; Richter G; Bardutzky J; Kollmar R; Mäurer M; Schellinger PD; Hilz MJ; Doerfler A; Schwab S; Huttner HB
Cerebrovasc Dis; 2009; 27(2):146-50. PubMed ID: 19039218
[TBL] [Abstract][Full Text] [Related]
8. What is the effect of low-molecular weight heparin for venous thromboembolism prophylaxis compared with mechanical methods, on the occurrence of hemorrhagic and venous thromboembolic complications in patients with intracerebral hemorrhage? A critically appraised topic.
O'Carroll CB; Capampangan DJ; Aguilar MI; Bravo TP; Hoffman-Snyder CR; Wingerchuk DM; Wellik KE; Demaerschalk BM
Neurologist; 2011 Jul; 17(4):232-5. PubMed ID: 21712672
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Venous Thromboembolism Prophylactic Measures Post Coronary Artery Bypass Graft Surgery.
Wilsey HA; Pandya K; Beavers C; Xiaoshu L; Ather A
Am J Cardiovasc Drugs; 2019 Dec; 19(6):589-595. PubMed ID: 31203501
[TBL] [Abstract][Full Text] [Related]
10. Unfractionated Heparin TID Dosing Regimen Is Associated With a Lower Rate of Pulmonary Embolism When Compared With BID Dosing in Patients Undergoing Craniotomy.
Thirunavu V; Kandula V; Shah P; Yerneni K; Karras CL; Abecassis ZA; Bloch O; Potts M; Jahromi B; Tate MC
World Neurosurg; 2021 Sep; 153():e147-e152. PubMed ID: 34166830
[TBL] [Abstract][Full Text] [Related]
11. Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial.
Pineo G; Lin J; Stern L; Subrahmanian T; Annemans L
J Hosp Med; 2012 Mar; 7(3):176-82. PubMed ID: 22058011
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.
Kociol RD; Hammill BG; Hernandez AF; Klaskala W; Mills RM; Curtis LH; Fonarow GC
Clin Cardiol; 2011 Nov; 34(11):682-8. PubMed ID: 22057910
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
14. Risks for hemorrhagic complications after placement of external ventricular drains with early chemical prophylaxis against venous thromboembolisms.
Tanweer O; Boah A; Huang PP
J Neurosurg; 2013 Nov; 119(5):1309-13. PubMed ID: 23991846
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
17. Early thrombosis prophylaxis with enoxaparin is not associated with hematoma expansion in patients with spontaneous intracerebral hemorrhage.
Ianosi B; Gaasch M; Rass V; Huber L; Hackl W; Kofler M; Schiefecker AJ; Addis A; Beer R; Rhomberg P; Pfausler B; Thomé C; Ammenwerth E; Helbok R
Eur J Neurol; 2019 Feb; 26(2):333-341. PubMed ID: 30308696
[TBL] [Abstract][Full Text] [Related]
18. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
[TBL] [Abstract][Full Text] [Related]
19. Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients.
Laporte S; Liotier J; Bertoletti L; Kleber FX; Pineo GF; Chapelle C; Moulin N; Mismetti P
J Thromb Haemost; 2011 Mar; 9(3):464-72. PubMed ID: 21232002
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage: what do we know about risks and benefits?
Masotti L; Godoy DA; Di Napoli M; Rabinstein AA; Paciaroni M; Ageno W
Clin Appl Thromb Hemost; 2012 Jul; 18(4):393-402. PubMed ID: 22609819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
